Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
Globe Newswire•09/10/2026•08:00 ET
0
Key Highlights
- ➤Filana management to attend 2026 Maxim Growth Summit October 12–14
- ➤One-on-one meetings scheduled at New York’s Hard Rock Hotel NYC
- ➤Filana develops investigational filamin A therapies for TSC-related epilepsy
AUSTIN, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for the treatment of Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced that the Company’s management team will participate in the 2026 Maxim Growth Summit being held October 12-14, 2026 in New York.
Format: One-on-one meetings Date: October 12–14, 2026 Location: The Hard Rock Hotel NYC
Get started
Create a free account to read the full story.